PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
PEN vs. LLY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between PEN and LLY is 0.18, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

PEN vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Penumbra, Inc. (PEN) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%30.00%40.00%SeptemberOctoberNovemberDecember2025February
44.26%
-8.05%
PEN
LLY

Key characteristics

Sharpe Ratio

PEN:

0.30

LLY:

0.40

Sortino Ratio

PEN:

0.74

LLY:

0.77

Omega Ratio

PEN:

1.09

LLY:

1.10

Calmar Ratio

PEN:

0.23

LLY:

0.51

Martin Ratio

PEN:

0.54

LLY:

1.18

Ulcer Index

PEN:

22.17%

LLY:

10.53%

Daily Std Dev

PEN:

40.13%

LLY:

30.89%

Max Drawdown

PEN:

-62.64%

LLY:

-68.27%

Current Drawdown

PEN:

-11.90%

LLY:

-8.74%

Fundamentals

Market Cap

PEN:

$11.70B

LLY:

$779.75B

EPS

PEN:

$0.36

LLY:

$11.74

PE Ratio

PEN:

843.78

LLY:

73.85

PEG Ratio

PEN:

-62.27

LLY:

0.87

Total Revenue (TTM)

PEN:

$1.19B

LLY:

$45.04B

Gross Profit (TTM)

PEN:

$750.02M

LLY:

$36.76B

EBITDA (TTM)

PEN:

$43.06M

LLY:

$15.63B

Returns By Period

In the year-to-date period, PEN achieves a 27.64% return, which is significantly higher than LLY's 13.29% return.


PEN

YTD

27.64%

1M

13.02%

6M

53.42%

1Y

17.35%

5Y*

9.58%

10Y*

N/A

LLY

YTD

13.29%

1M

17.82%

6M

-8.18%

1Y

17.81%

5Y*

45.73%

10Y*

30.99%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

PEN vs. LLY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PEN
The Risk-Adjusted Performance Rank of PEN is 5454
Overall Rank
The Sharpe Ratio Rank of PEN is 5757
Sharpe Ratio Rank
The Sortino Ratio Rank of PEN is 5252
Sortino Ratio Rank
The Omega Ratio Rank of PEN is 5050
Omega Ratio Rank
The Calmar Ratio Rank of PEN is 5757
Calmar Ratio Rank
The Martin Ratio Rank of PEN is 5353
Martin Ratio Rank

LLY
The Risk-Adjusted Performance Rank of LLY is 5959
Overall Rank
The Sharpe Ratio Rank of LLY is 6161
Sharpe Ratio Rank
The Sortino Ratio Rank of LLY is 5353
Sortino Ratio Rank
The Omega Ratio Rank of LLY is 5252
Omega Ratio Rank
The Calmar Ratio Rank of LLY is 6868
Calmar Ratio Rank
The Martin Ratio Rank of LLY is 6060
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

PEN vs. LLY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Penumbra, Inc. (PEN) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for PEN, currently valued at 0.30, compared to the broader market-2.000.002.000.300.40
The chart of Sortino ratio for PEN, currently valued at 0.74, compared to the broader market-4.00-2.000.002.004.006.000.740.77
The chart of Omega ratio for PEN, currently valued at 1.09, compared to the broader market0.501.001.502.001.091.10
The chart of Calmar ratio for PEN, currently valued at 0.23, compared to the broader market0.002.004.006.000.230.51
The chart of Martin ratio for PEN, currently valued at 0.54, compared to the broader market-10.000.0010.0020.0030.000.541.18
PEN
LLY

The current PEN Sharpe Ratio is 0.30, which is comparable to the LLY Sharpe Ratio of 0.40. The chart below compares the historical Sharpe Ratios of PEN and LLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
0.30
0.40
PEN
LLY

Dividends

PEN vs. LLY - Dividend Comparison

PEN has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.62%.


TTM20242023202220212020201920182017201620152014
PEN
Penumbra, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
LLY
Eli Lilly and Company
0.62%0.67%0.78%1.07%1.23%1.75%1.96%1.95%2.46%2.77%2.37%2.84%

Drawdowns

PEN vs. LLY - Drawdown Comparison

The maximum PEN drawdown since its inception was -62.64%, smaller than the maximum LLY drawdown of -68.27%. Use the drawdown chart below to compare losses from any high point for PEN and LLY. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-11.90%
-8.74%
PEN
LLY

Volatility

PEN vs. LLY - Volatility Comparison

Penumbra, Inc. (PEN) has a higher volatility of 12.73% compared to Eli Lilly and Company (LLY) at 7.17%. This indicates that PEN's price experiences larger fluctuations and is considered to be riskier than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%16.00%18.00%SeptemberOctoberNovemberDecember2025February
12.73%
7.17%
PEN
LLY

Financials

PEN vs. LLY - Financials Comparison

This section allows you to compare key financial metrics between Penumbra, Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab